FDA orphan drug designation: treatment of T-cell lymphoma
All entries for: Nanjing Miracle Biotechnology Co.Ltd.
September 12, 2025
Nanjing Miracle Biotechnology Co.Ltd.
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of T-cell lymphoma
